Evaluation of gut bacterial community composition and antimicrobial resistome in pregnant and non-pregnant women from Saudi population
Infection and Drug Resistance
Dovepress
open access to scientific and medical research
Infection and Drug Resistance downloaded from https://www.dovepress.com/ by 88.198.20.149 on 23-Sep-2019
For personal use only.
Open Access Full Text Article
Evaluation of gut bacterial community
composition and antimicrobial resistome in
pregnant and non-pregnant women from Saudi
population
This article was published in the following Dove Press journal:
Infection and Drug Resistance
Imran Khan 1–3, *
Muhammad Yasir 1,4, *
Muhammad Farman 1,5
Taha Kumosani 6
Samera F AlBasri 7
Osama S Bajouh 7
Esam I Azhar 1,4
1
Special Infectious Agents Unit, King Fahd
Medical Research Center, King Abdulaziz
University, Jeddah, Saudi Arabia;
2
Biochemistry Department, Faculty of
Science; Special Infectious Agents Unit,
King Fahd Medical Research Center, King
Abdulaziz University, Jeddah, Saudi Arabia;
3
State Key Laboratory of Quality Research
in Chinese Medicine, Macau University of
Science and Technology Taipa, Macau,
People’s Republic of China; 4Medical
Laboratory Technology Department,
Faculty of Applied Medical Sciences, King
Abdulaziz University, Jeddah, Saudi Arabia;
5
Department of Biology, King Abdulaziz
University, Jeddah, Saudi Arabia;
6
Biochemistry Department, Faculty of
Science; Production of Bio-products for
Industrial Applications Research Group,
and Experimental Biochemistry Unit, King
Fahd Medical Research Center, King
Abdulaziz University, Jeddah, Saudi Arabia;
7
Department of Obstetrics & Gynecology,
King Abdul Aziz University Hospital,
Jeddah, Saudi Arabia
*These authors contributed equally to this
work
Background: Gut microbiota (GM) has recently been described as a functional reservoir of
antimicrobial resistant genes (ARGs). However, the ARG-carrying bacterial species in the
human gut has been poorly studied. This study, for the first time, is reporting bacterial
communities' composition and antimicrobial resistome in the stool samples of pregnant and
non-pregnant (NP) Saudi females.
Methods: Gut bacterial community composition was analyzed by 16S amplicon sequencing
and culturomics. High throughput MALDI-TOF technique was used for identification of the
isolates from stool samples and evaluated for resistance against 13 antibiotics using the agar
dilution method. Clinically important ARGs were PCR amplified from genomic DNA of the
stool samples using gene-specific primers.
Results: 16S amplicon sequencing revealed that GM of pregnant and NP women were predominantly comprised of phyla Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria.
Bacterial diversity decreased in pregnant groups, whereas phylum Bacteroidetes declined significantly (p<0.05) in the first trimester. We noticed a relatively high abundance of butyrateproducing bacteria (eg, Faecalibacterium spp. and Eubacterium spp.) in the gut of pregnant
women, whereas Prevotella copri was found at significantly (p<0.01) higher abundance in NP
women. Moreover, about 14,694 isolates were identified and classified into 132 distinct species.
The majority of the species belonged to phyla Firmicutes and Proteobacteria. About 8,125 isolates
exhibited resistance against antibiotics. Out of 73 resistant-species, Enterococcus was the most
diverse genus and Escherichia coli was the highly prevalent bacterium. The majority of the
isolates were resistant to antibiotics; trimethoprim/sulfamethoxazole, cycloserine, and cefixime.
ARGs encoding resistance against aminoglycoside, macrolide, quinolone, β-lactam, and tetracycline antibiotics were predominantly found in genomic DNA of the stool samples.
Conclusion: We conclude that pregnancy-associated GM modulations may help to sustain
a healthy pregnancy, but a higher proportion of antibiotic resistance could be deleterious for
both maternal and fetal health.
Keywords: gut microbiota, antimicrobial resistance, metagenomics, culturomics, pregnancy,
Saudi Arabia
Correspondence: Muhammad Yasir
Special Infectious Agents Unit, King Fahd
Medical Research Center, King Abdulaziz
University, Jeddah 21589, Saudi Arabia
Tel +96 656 320 2241
Email
Introduction
submit your manuscript | www.dovepress.com
Infection and Drug Resistance 2019:12 1749–1761
DovePress
© 2019 Khan et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
http://doi.org/10.2147/IDR.S200213
Powered by TCPDF (www.tcpdf.org)
ORIGINAL RESEARCH
During pregnancy, women undergo complex physiological changes that are accompanied by changes in the diversity and composition of gut microbiota (GM).1,2 Any
change in GM composition and diversity may eventually affect host immunity,
1749
Dovepress
Infection and Drug Resistance downloaded from https://www.dovepress.com/ by 88.198.20.149 on 23-Sep-2019
For personal use only.
Khan et al
digestion, and metabolism.3–5 Pregnancy-associated GM
modulations, especially an enriched abundance of the
phyla Proteobacteria and Actinobacteria, have been associated with the increased energy uptake that occurs during
pregnancy.2,6
The health implications of pregnancy-associated GM
modulation are still unclear; first, because GM diversity
and composition are plastic in nature and vary significantly
with geography and diet,7 and secondly, because the pregnancy–GM association has been studied in only a few
geographical locations.1,2,8–10 In addition, unprecedented
use of antibiotics could substantially affect GM diversity.11
Increased prescription of antibiotics during pregnancy,
which has been reported in several countries,12–14 could
decrease GM diversity during pregnancy and may be deleterious for both maternal and fetal health. Furthermore,
unnecessary and inappropriate use of antibiotics could
induce teratogenicity, modulate GM composition, and contribute to the emergence of antimicrobial-resistant
pathogens.15,16
Human GM has become a functional reservoir of antimicrobial resistance genes (ARGs)17 that could potentially
be acquired by opportunistic pathogens.17,18 These pathogens could translocate from the gut to various body sites
through fecal contamination, gut barrier penetration, and
medical services (such as catheter replacement).19,20 Such
pathogens could further complicate infections, especially
in immune-compromised individuals (including pregnant
women and infants),21,22 and stress health care resources.
Bacterial pathogens carrying ARGs could affect ovum
implantation, pregnancy sustention, and delivery, and
they (...truncated)